CCL25 and ovarian carcinoma: Singh et al (6) adopted the Aperio analysis method and demonstrated that ovarian cancer cells express chemokine receptor, CCR9 and its ligand, CCL25 and indicated that this chemokine-receptor axis may be involved in ovarian cancer progression.